[1]胡嘉健,孙记航,陈艺伟,等.影像学危险因素对儿童腹膜后神经母细胞瘤手术并发症的预测价值研究[J].临床小儿外科杂志,2020,19(10):903-908.[doi:10.3969/j.issn.1671-6353.2020.10.008]
 Hu Jiajian,Sun Jihang,Chen Yiwei,et al.Correlational research between image danger risk factor and surgical complications of retroperitoneal neuroblastoma in children[J].Journal of Clinical Pediatric Surgery,2020,19(10):903-908.[doi:10.3969/j.issn.1671-6353.2020.10.008]
点击复制

影像学危险因素对儿童腹膜后神经母细胞瘤手术并发症的预测价值研究

参考文献/References:

1 Yoneda A,Nishikawa M,Uehara S,et al.Can neoadjuvant chemotherapy reduce the surgical risks for localized neuroblastoma patients with image-defined risk factors at the time of diagnosis?[J].Pediatr Surg Int,2016,32(3):209-214.DOI:10.1007/s00383-016-3858-5.
2 马晓莉,金眉,张大伟,等.多学科联合诊治神经母细胞瘤91例临床特征及近期疗效分析[J].中华实用儿科临床杂志,2013,28(3):178-182.DOI:10.3760/cma.j.issn.2095-428X.2013.03.007. Ma XL,Jin M,Zhang DW,et al.Clinical features and efficacy of recent treatment analysis of multimodality treatment for 91 children with neuroblastoma[J].J Appl Clin Ped,2013,28(3):178-182.DOI:10.3760/cma.j.issn.2095-428X.2013.03.007.
3 张金哲.小儿肿瘤外科手术技术规范[J].临床小儿外科杂志,2008,7(5):66-68.DOI:10.3969/j.issn.1671-6353.2008.05.023. Zhang JZ.Technical specifications for pediatric oncological surgery[J].J Clin Ped Sur,2008,7(5):66-68.DOI:10.3969/j.issn.1671-6353.2008.05.023.
4 Brodeur GM,Pritchard J,Berthold F,et al.Revisions of the international criteria for neuroblastoma diagnosis,staging and response to treatment[J].Prog Clin Biol Res,1993,385(11):363-369.
5 张广超,王景福.国际神经母细胞瘤危险度分级(INRG)协作组最新共识[J].中国肿瘤临床,2012,39(15):1003-1007.DOI:10.3969/j.issn.1000-8179.2012.15.001. Zhang GC,Wang JF.Latest staging consensus of International Neuroblastoma Risk Group[J].Chin J Clin Onc,2012,39(15):1003-1007.DOI:10.3969/j.issn.1000-8179.2012.15.001.
6 Brisse HJ,McCarville MB,Granata C,et al.Guidelines for Imaging and Staging of Neuroblastic Tumors:Consensus Report from the International Neuroblastoma Risk Group[J].Radiol,2011,261(1):243-257.DOI:10.1148/radiol.11101352.
7 Davidoff AM,Fernandez-Pineda I.Complications in the surgical management of children with malignant solid tumors[J].Semin Pediatr Surg,2016,25(6):395-403.DOI:10.1053/j.sempedsurg.2016.10.003.
8 Akihiro Y,Masanori N,Shuichiro U,et al.Can Image-Defined Risk Factors Predict Surgical Complications in Localized Neuroblastoma?[J].Eur J Pediatr Surg,2016,26(1):117-122.DOI:10.1055/s-0035-1566100.
9 Cecchetto G,Mosseri V,De Bernardi B,et al.Surgical risk factors in primary surgery for localized neuroblastoma:the LNESG1study of the European International Society of Pediatric Oncology Neuroblastoma Group[J].J Clin Oncol,2005,23(33):8483-8489.DOI:10.1200/JCO.2005.02.4661. 10 Cohn SL,Pearson AD,London WB,et al.The International Neuroblastoma Risk Group (INRG) classification system:an INRG Task Force report[J].J Clin Oncol,2009,27(2):289-297.DOI:10.1200/JCO.2008.16.6875.
11 Fumino S,Kimura K,Iehara T,et al.Validity of image-defined risk factors in localized neuroblastoma:A report from two centers in Western Japan[J].J Ped Surg,2015,50(12):2102-2106.DOI:10.1016/j.jpedsurg.2015.08.039. 12 Monclair T,Mosseri V,Cecchetto G,et al.Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma.A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group[J].Pediatr Blood Cancer,2015,62(9):1536-1542.DOI:10.1002/pbc.25460.
13 Günther P,Holland-cunz S,Schupp CJ,et al.Significance of image-defined risk factors for surgical complications in patients with abdominal neuroblastoma[J].Eur J Pediatr Surg,2011,21(5):314-317.DOI:10.1055/s-0031-1280824.
14 Simon T,Hero B,Benzbohm G,et al.Review of image defined risk factors in localized neuroblastoma patients:Results of the GPOH NB97 trial[J].Pediatr Blood Cancer,2010,50(5):965-969.DOI:10.1002/pbc.21343.
15 Avanzini S,Pio L,Erminio G,et al.Image-defined risk factors in unresectable neuroblastoma:SIOPEN study on incidence,chemotherapy-induced variation,and impact on surgical outcomes[J].Pediatr Blood Cancer,2017,64(11):e26605.DOI:10.1002/pbc.26605.
16 Mullassery D,Farrelly P,Losty PD.Does aggressive surgical resection improve survival in advanced stage 3 and 4neuroblastoma? A systematic review and meta-analysis[J].Pediatr Hematol Oncol,2014,31(8):703-716.DOI:10.3109/08880018.2014.947009.
17 Englum BR,Rialon KL,Speicher PJ,et al.Value of surgical resection in children with high-risk neuroblastoma[J].Pediatr Blood Cancer,2015,62(9):1529-1535.DOI:10.1002/pbc.25504.
18 王焕民.神经母细胞瘤外科治疗的技术与原则[J].中国小儿血液与肿瘤杂志,2014,19(1):7-9.DOI:10.3969/j.issn.1673-5323.2014.01.003. Wang HM.Techniques and principles of surgical treatment of neuroblastoma[J].China Pediatr Blood Cancer,2014,19(1):7-9.DOI:10.3969/j.issn.1673-5323.2014.01.003. 19 Brisse HJ,Mccarville MB,Granata C,et al.Guidelines for Imaging and Staging of Neuroblastic Tumors:consensus report from the International Neuroblastoma Risk Group Project[J].Radiol,2011,261(1):243-257.DOI:10.1148/radiol.11101352.
20 Lim Ⅱ,Goldman DA,Farber BA,et al.Image-defined risk factors for nephrectomy in patients undergoing neuroblastoma resection[J].J Pediatr Surg,2016,51(6):975-980.DOI:10.1016/j.jpedsurg.2016.02.069.
21 Ibrahim D.Indications for nephrectomy in children:a report on 119 cases[J].Saudi J Kidney Dis Transpl,2012,23(6):1221-1226.DOI:10.4103/1319-2442.103563.
22 Paran TS,Corbally MT,Gross-Rom E,et al.Experience with aortic grafting during excision of large abdominal neuroblastomas in children[J].J Pediatr Surg,2008,43(2):335-340.DOI:10.1016/j.jpedsurg.2007.10.045.
23 Liu Y,Pan C,Tang JY,et al.What is the result:chylous leakage following extensive radical surgery of neuroblastoma[J].World J Pediatr,2012,8(2):151-155.DOI:10.1007/s12519-011-0296-2.
24 Chui CH.Mesenteric lymphatic ligation in the prevention of chylous fistulae in abdominal neuroblastoma surgery[J].Pediatr Surg Int,2014,30(10):1009-1012.DOI:10.1007/s00383-014-3581-z.
25 齐立行,李志霞.术后早期肠梗阻及其治疗策略[J].中华普通外科杂志,2000,15(2):95-97.DOI:10.3760/j.issn:1007-631X.2000.02.010. Qi LX,Li ZX.Early postoperative intestinal obstruction and its therapeutic strategies[J].Chin J Gener Surg,2000,15(2):95-97.DOI:10.3760/j.issn:1007-631X.2000.02.010.

相似文献/References:

[1]郭春宝,王珊,金先庆,等.Cochrane系统评价方法对神经母细胞瘤分子与生物标记物的Meta分析[J].临床小儿外科杂志,2008,7(01):2.
[2]未德成,王忠荣,张燕敏,等.脂氧合酶抑制剂NDGA对人神经母细胞瘤SK-N-SH细胞生物学特性的影响[J].临床小儿外科杂志,2008,7(01):3.
[3]陈新让,王家祥,余捷凯,等.基于支持向量机神经母细胞瘤血清蛋白质标记物的检测及临床应用[J].临床小儿外科杂志,2008,7(02):12.
[4]罗远建,金科,甘青,等.儿童神经母细胞瘤的影像学表现[J].临床小儿外科杂志,2007,6(02):22.
[5]李昆昆 金先庆 牟廷刚 陈建飞 赵利华 丁雄辉 孙艳辉 王士奇. ATRA耐药基因HA117相关蛋白在四种恶性肿瘤的表达及临床意义[J].临床小儿外科杂志,2011,10(04):250.
 [J].Journal of Clinical Pediatric Surgery,2011,10(10):250.
[6]沙永亮 吴晔明. 化疗及非化疗组神经母细胞瘤干细胞标志物的表达及意义[J].临床小儿外科杂志,2011,10(04):254.
 [J].Journal of Clinical Pediatric Surgery,2011,10(10):254.
[7]刘涛 韩英 祝秀丹 王焕民 秦红 邹焱. Wnt—5a基因在神经母细胞瘤中的表达及意义[J].临床小儿外科杂志,2011,10(05):333.
 [J].Journal of Clinical Pediatric Surgery,2011,10(10):333.
[8]顾 涛 鹿洪亭 董 蒨.Kai1/CD82表达水平与神经母细胞瘤转移的关系探讨[J].临床小儿外科杂志,2013,12(02):100.[doi:10.3969/j.issn.1671— 6353.2013.02.007]
 GU Tao,LU Hong-ting,DONG Qian.The relationship between Kai1/CD82 expression and metastasis of neuroblastoma[J].Journal of Clinical Pediatric Surgery,2013,12(10):100.[doi:10.3969/j.issn.1671— 6353.2013.02.007]
[9]邢莉莉,吴晔明,张弛.熊果酸对神经母细胞瘤细胞增殖凋亡及 MYCN表达的影响[J].临床小儿外科杂志,2013,12(03):196.[doi:10.3969/j.issn.1671—6353.2013.03.010]
 XING Li li,WU Ye ming,ZHANG Chi..Ursolic acid effects proliferation、apoptosis and MYCN expression of neuroblastoma cell[J].Journal of Clinical Pediatric Surgery,2013,12(10):196.[doi:10.3969/j.issn.1671—6353.2013.03.010]
[10]林正秀,赵一鸣,李仲荣,等.小儿腹膜后畸胎瘤29例诊治体会[J].临床小儿外科杂志,2013,12(03):209.[doi:10.3969/j.issn.1671—6353.2013.03.013]
 LIN Zheng xiu,ZHAO Yi ming,LI Zhong rong,et al.The diagnosis and treatment of 29 cases of pediatric retroperitoneal teratoma[J].Journal of Clinical Pediatric Surgery,2013,12(10):209.[doi:10.3969/j.issn.1671—6353.2013.03.013]

备注/Memo

收稿日期:2019-01-13。
通讯作者:王焕民,Email:wanghuanmin@bch.com.cn

更新日期/Last Update: 2020-10-28